Cell entry of dengue virus

Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

Bibliography

• 1  Gubler DJ: Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev.11,480–496 (1998).
  Medline CASGoogle Scholar
• 2  Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS: Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg.40,444–451 (1989).
  Medline CASGoogle Scholar
• 3  Rothman AL: Dengue: defining protective versus pathologic immunity. J. Clin. Inv.113,946–951 (2004).
  Medline CASGoogle Scholar
• 4  Gubler DJ: Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol.10,100–103 (2002).
  Medline CASGoogle Scholar
• 5  Salas-Benito JS, del Angel RM: Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J. Virol.71,7246–7252 (1997).
  Medline CASGoogle Scholar
• 6  Salas-Benito J, Reyes-Del Valle J, Salas-Benito M, Ceballos-Olvera I, Mosso C, del Angel RM: Evidence that the 45-kD glycoprotein, part of a putative dengue virus receptor complex in the mosquito cell line C6/36, is a heat-shock related protein. Am. J. Trop. Med. Hyg.77,283–290 (2007).
  Medline CASGoogle Scholar
• 7  Muñoz ML, Cisneros A, Cruz J, Das P, Tovar R, Ortega A: Putative dengue virus receptors from mosquito cells. FEMS Microbiol. Lett.168,251–258 (1998).
  Medline CASGoogle Scholar
• 8  Chee H-Y, AbuBakar S: Identification of a 48 kDa tubulin or tubulin-like C6/36 mosquito cells protein that binds dengue virus 2 using mass spectrometry. Biochem. Biophys. Res. Commun.320,11–17 (2004).
  Medline CASGoogle Scholar
• 9  Sakoonwatanyoo P, Boonsanay V, Smith DR: Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein. InterVirology49,161–172 (2006).
  Medline CASGoogle Scholar
• 10  Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol.79,4557–4567 (2005).
  Medline CASGoogle Scholar
• 11  Jindadamrongwech S, Thepparit C, Smith DR: Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol.149,915–927 (2004).
  Medline CASGoogle Scholar
• 12  Thepparit C, Smith DR: Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J. Virol.78,12647–12656 (2004).
  Medline CASGoogle Scholar
• 13  Miller JL, Dewet BJ, Martinez-Pomares L et al.: The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog.4,e17(2008).
  MedlineGoogle Scholar
• 14  Chen Y, Maguire T, Marks RM: Demonstration of binding of dengue virus envelope protein to target cells. J. Virol.70,8765–8772 (1996).
  Medline CASGoogle Scholar
• 15  Chen YC, Wang SY, King CC: Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol.73,2650–2657 (1999).
  Medline CASGoogle Scholar
• 16  Navarro-Sanchez E, Altmeyer R, Amara A et al.: Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep.4,723–728 (2003).
  Medline CASGoogle Scholar
• 17  Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al.: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med.197,823–829 (2003).
  Medline CASGoogle Scholar
• 18  Marianneau P, Mégret F, Olivier R, Morens DM, Deubel V: Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J. Gen. Virol.77,2547–2554 (1996).
  Medline CASGoogle Scholar
• 19  Rothwell SW, Putnak R, La Russa VF: Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. Am. J. Trop. Med. Hyg.54,503–510 (1996).
  Medline CASGoogle Scholar
• 20  Ramos-Castañeda J, Imbert JL, Barron BL, Ramos C: A 65-kDa trypsin sensible membrane cell protein as a posible receptor for dengue virus in cultured neuroblastoma cells. J. Neurovirol.3,435–440 (1997).
  Medline CASGoogle Scholar
• 21  Bielefeldt-Ohmann H: Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res.57,63–79 (1998).
  Medline CASGoogle Scholar
• 22  Bielefeldt-Ohmann H, Meyer M, Fitzpatrick DR, Mackenzie JS: Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res.73,81–89 (2001).
  Medline CASGoogle Scholar
• 23  Martínez-Barragán JJ, del Angel RM: Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J. Virol.75,7818–7827 (2001).• An early study demonstrating two sequential receptors, heparan sulfate and a protein, for Dengue virus (DENV).
  Medline CASGoogle Scholar
• 24  Moreno-Altamirano MMB, Sánchez-García FJ, Muñoz ML: Non Fc receptor-mediated infection of human macrophages by dengue virus serotype 2. J. Gen. Virol.83,1123–1130 (2002).
  Medline CASGoogle Scholar
• 25  Wei HY, Jiang LF, Fang DY, Guo HY: Dengue virus type 2 infects human endothelial cells through binding of the viral envelope glycoprotein to cell surface polypeptides. J. Gen. Virol.84,3095–3098 (2003).
  Medline CASGoogle Scholar
• 26  Chen Y, Maguire T, Hileman RE et al.: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med.3,866–871 (1997).
  Medline CASGoogle Scholar
• 27  Hung SL, Lee PL, Chen HW, Chen LK, Kao CL, King CC: Analysis of the steps involved in dengue virus entry into host cells. Virology257,156–167 (1999).
  Medline CASGoogle Scholar
• 28  Hilgard P, Stockert R: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology32,1069–1077 (2000).
  Medline CASGoogle Scholar
• 29  Germi R, Crance JM, Garin D et al.: Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology292,162–168 (2002).
  Medline CASGoogle Scholar
• 30  Spillmann D: Heparan sulfate: anchor for viral intruders. Biochimie83,811–817 (2001).
  Medline CASGoogle Scholar
• 31  Lin YL, Lei HY, Lin YS, Yeh TM, Chen SH, Liu HS: Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res.56,93–96 (2002).
  Medline CASGoogle Scholar
• 32  Talarico LB, Pujol CA, Zibetti RGM et al.: The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res.66,103–110 (2005).• Study suggesting the dependence of DENV entry on virus serotype and host cell.
  Medline CASGoogle Scholar
• 33  Lozach PY, Burleigh L, Staropoli I et al.: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem.280,23698–23708 (2005).
  Medline CASGoogle Scholar
• 34  Pelkmans L: Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta1749,295–304 (2005).• Description of the new nonclathrin-mediated endocytic routes used by certain viruses.
  Google Scholar
• 35  Kirkham M, Parton RG: Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta1745,273–286 (2005).
  Medline CASGoogle Scholar
• 36  Sieczkarski SB, Whittaker GR: Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol.76,10455–10464 (2005).
  Google Scholar
• 37  Marsh M, Helenius A: Virus entry: open sesame. Cell124,729–740 (2006).•• A comprehensive review of the entry pathways for virus entry.
  Medline CASGoogle Scholar
• 38  Hase T, Summers PL, Eckels KH: Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch. Virol.104,129–143 (1989).
  Medline CASGoogle Scholar
• 39  Lim HY, Ng ML: A different mode of entry by dengue-2 neutralization escape mutant virus. Arch. Virol.144,989–995 (1999).
  Medline CASGoogle Scholar
• 40  Krishnan MN, Sukumaran B, Pal U et al.: Rab 5 is required for the cellular entry of dengue virus and West Nile viruses. J. Virol.81,4881–4885 (2007).
  Medline CASGoogle Scholar
• 41  Acosta EG, Castilla V, Damonte EB: Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J. Gen. Virol.89,474–484 (2008).
  Medline CASGoogle Scholar
• 42  Hu H-P, Hsieh SC, King C-C, Wang W-K: Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses. Virology368,376–387 (2007).
  Medline CASGoogle Scholar
• 43  Randolph VB, Stollar V: Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. J. Gen. Virol.71,1845–1850 (1990).
  MedlineGoogle Scholar
• 44  van der Schaar HM, Rust MJ, Waarts B-L et al.: Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J. Virol.81,12019–12028 (2007).
  Medline CASGoogle Scholar
• 45  Modis Y, Ogata S, Clements D, Harrison SC: Structure of the dengue virus envelope protein after membrane fusion. Nature427,313–319 (2004).•• Demonstrates the conformational changes in E glycoprotein after fusion.
  Medline CASGoogle Scholar
• 46  Zhang Y, Zhang W, Ogata S et al.: Conformational changes of the flavivirus E glycoprotein. Structure12,1607–1618 (2004).
  Medline CASGoogle Scholar
• 47  Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol.3,13–22 (2005).
  Medline CASGoogle Scholar
• 48  Stiasny K, Heinz FX: Flavivirus membrane fusion. J. Gen. Virol.87,2755–2766 (2006).
  Medline CASGoogle Scholar
• 49  Lee C-J, Lin H-R, Liao C-L, Lin Y-L: Cholesterol effectively blocks entry of flavivirus infection. J. Virol.82,6470–6480 (2008).
  Medline CASGoogle Scholar
• 50  Altmeyer R: Virus attachment and entry offer numerous targets for antiviral therapy. Curr. Pharm. Des.10,3701–3712 (2004).
  Medline CASGoogle Scholar
• 51  Thaisomboonsuk BK, Clayson ET, Pantuwatana S, Vaughn DW, Endy TP: Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells. Am. J. Trop. Med. Hyg.72,375–383 (2005).
  Medline CASGoogle Scholar
• 52  Marks RM, Lu H, Sundaresan R et al.: Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors. J. Med. Chem.44,2178–2187 (2001).
  Medline CASGoogle Scholar
• 53  Lee E, Pavy M, Young N, Freeman C, Lobigs M: Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res.69,31–38 (2006).
  Medline CASGoogle Scholar
• 54  Pujol CA, Estévez JM, Carlucci MJ, Ciancia M, Cerezo AS, Damonte EB: Novel DL-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus. Antivir. Chem. Chemother.13,83–89 (2002).
  Medline CASGoogle Scholar
• 55  Talarico LB, Duarte MER, Zibetti RGM, Noseda MD, Damonte EB: An algal derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection. Planta Med.73,1464–1468 (2007).
  Medline CASGoogle Scholar
• 56  Qiu H, Tang W, Tong X, Ding K, Zuo J: Structure elucidation and sulfated derivatives preparation of two α-D-glucans from Gastrodia elata B1 and their anti-dengue virus bioactivities. Carbohydr. Res.342,2230–2236 (2007).
  Medline CASGoogle Scholar
• 57  Rodríguez MC, Merino ER, Pujol CA, Damonte EB, Cerezo AS, Matulewicz MC: Galactans from cystocarpic plants of the red seaweed Callophyllis variegata (Kallymeniaceae, Gigartinales). Carbohydr. Res.340,2742–2751 (2005).
  Medline CASGoogle Scholar
• 58  Tischer PCSF, Talarico LB, Noseda MD, Guimaraes SMPB, Damonte EB, Duarte MER: Chemical structure and antiviral activity of carrageenans from Meristiella gelidium against herpes simplex and dengue virus. Carbohydr. Polym.63,459–465 (2006).
  Google Scholar
• 59  Talarico LB, Damonte EB: Interference in dengue virus adsorption and uncoating by carrageenans. Virology363,473–485 (2007).
  Medline CASGoogle Scholar
• 60  Ono L, Wollinger W, Rocco IM, Coimbra TLM, Gorin PAJ, Sierakowski MR: In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res.60,201–208 (2003).
  Medline CASGoogle Scholar
• 61  Shigeta S, Mori S, Kodama E, Kodama J, Takahashi K, Yamase T: Broad-spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates. Antiviral Res.58,265–271 (2003).
  Medline CASGoogle Scholar
• 62  Damonte EB, Pujol CA, Coto CE: Prospects for the therapy and prevention of dengue virus infections. Adv.Virus Res.63,239–285 (2004).
  Medline CASGoogle Scholar
• 63  Koff WC, Elm JL Jr, Halstead SB: Inhibition of dengue virus replication by amantadine hydrochloride. Antimicrob. Agents Chemother.18,125–129 (1980).
  Medline CASGoogle Scholar
• 64  Koff WC, Elm JL Jr, Halstead SB: Suppression of dengue virus replication in vitro by rimantadine hydrochloride. Am. J. Trop. Med. Hyg.30,184–189 (1981).
  Medline CASGoogle Scholar
• 65  Nawa M, Takasaki T, Yamada K, Kurane I, Akatsuka T: Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine. J. Gen. Virol.84,1737–1741 (2003).
  Medline CASGoogle Scholar
• 66  Kuhn RJ, Zhang W, Rossmann MG et al.: Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell108,717–725 (2002).
  Medline CASGoogle Scholar
• 67  Modis Y, Ogata S, Clements D, Harrison SC: A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl Acad. Sci. USA100,6986–6991 (2003).
  Medline CASGoogle Scholar
• 68  Modis Y, Ogata S, Clements D, Harrison SC: Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol.79,1223–1231 (2005).
  Medline CASGoogle Scholar
• 69  Volk DE, Lee Y-C, Li X et al.: Solution structure of the envelope protein domain III of dengue-4 virus. Virology364,147–154 (2007).
  Medline CASGoogle Scholar
• 70  Hrobowski YM, Garry RF, Michael SF: Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol. J.2,49 (2005).
  MedlineGoogle Scholar
• 71  Yang J-M, Chen Y-F, Tu Y-Y, Yen K-R, Yang Y-L: Combinatorial computational approaches to identity tetracycline derivatives as flavivirus inhibitors. PLoS One2,e428 (2007).
  MedlineGoogle Scholar